DeepLife

DeepLife is a biotech company with a mission to cure disease one cell at a time with Digital Twins of cells.

We develop novel approaches based on state-of the art multi-omics data, AI and systems engineering to identify molecular triggers driving diseased cells back in their healthy state.

While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases.

The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, and proprietary deep learning-based cell engineering tools. Our goal is to supplement in vitro testing with in silico simulations and rapidly discover molecular triggers to efficiently engineer cell behavior.